Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals. Some, like ending birthright citizenship, are quickly slapped down in the courts. Some, ...
Your favorite toys and weight-loss drugs could be priced out of reach if Donald Trump is serious. Denmark’s defiant message ...
Job openings (Dec.) Factory orders (Dec.) Alphabet Inc (NASDAQ:GOOGL) (Q3) EPS for gain of $2.12, compared to $1.64 in the prior-year quarter. Toyota Motor Corporation (NYSE:TM) (Q3) EPS of $4.36, ...
First for Women on MSN17h
Amycretin Shows Promising 22% Weight Loss in Trials-It May Rival OzempicDrug manufacturer Novo Nordisk's amycretin, an experimental weight-loss pill in clinical trials, may boast substantial weight ...
Hosted on MSN21h
Pharma Stock Roundup: SNY and RHHBY's Q4 Earnings & MoreSanofi SNY and Roche RHHBY announced their fourth-quarter and full-year 2024 results. Novo Nordisk’s NVO novel obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback